|
雅各臣科研制药有限公司, 02633.HK - 综合损益表 |
2024-03 |
2023-03 |
2022-03 |
2021-03 |
2020-03 |
2019-03 |
2018-03 |
2017-03 |
2016-03 |
2015-03 |
2014-03 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
2004-12 |
营业额 |
1,467,798 |
1,267,598 |
1,595,543 |
1,445,915 |
1,571,459 |
1,478,125 |
1,548,684 |
1,255,957 |
1,083,856 |
947,591 |
926,181 |
622,561 |
283,760 |
178,322 |
167,339 |
163,584 |
经营溢利 |
333,126 |
313,384 |
260,888 |
256,240 |
318,217 |
370,585 |
297,228 |
235,242 |
185,520 |
138,842 |
222,917 |
-118,639 |
66,397 |
17,535 |
22,527 |
23,548 |
非经营/ 特殊项目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-253 |
联营公司 |
165 |
-1,627 |
-3,768 |
-5,527 |
628 |
4,719 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除税前经营溢利 |
254,583 |
250,345 |
231,433 |
220,569 |
263,486 |
309,106 |
251,223 |
221,246 |
182,997 |
136,135 |
216,948 |
-118,639 |
66,397 |
17,535 |
22,527 |
23,295 |
税项 |
44,414 |
42,976 |
43,728 |
34,264 |
46,025 |
55,528 |
46,323 |
39,986 |
30,335 |
22,157 |
32,247 |
3,295 |
5,655 |
214 |
389 |
545 |
少数股东权益 |
23,810 |
32,165 |
10,039 |
12,595 |
3,477 |
8,117 |
2,630 |
1,932 |
7,052 |
12,074 |
12,344 |
0 |
-117 |
-8 |
0 |
0 |
股东应占溢利 |
266,968 |
251,044 |
177,666 |
173,713 |
215,631 |
250,561 |
202,270 |
179,328 |
145,610 |
101,904 |
172,357 |
-121,934 |
60,859 |
17,329 |
22,138 |
22,750 |
货币 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
美元 |
美元 |
美元 |
美元 |
美元 |
单位 |
千 |
千 |
千 |
千 |
千 |
主要项目 |
折旧 |
141,823 |
148,653 |
192,597 |
191,701 |
170,775 |
115,916 |
112,434 |
81,981 |
69,928 |
52,945 |
43,996 |
17,255 |
6,499 |
6,380 |
4,758 |
4,053 |
利息 |
78,708 |
61,412 |
25,687 |
30,144 |
55,576 |
66,198 |
46,005 |
20,523 |
16,341 |
14,437 |
11,040 |
12,491 |
0 |
0 |
0 |
0 |
利息拨作发展资本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6,527 |
13,818 |
11,730 |
5,071 |
0 |
0 |
0 |
0 |
0 |
处置/重估固定资产 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
税率(%) |
17.45 |
17.17 |
18.89 |
15.53 |
17.47 |
17.96 |
18.44 |
18.07 |
16.58 |
16.28 |
14.86 |
|
8.52 |
1.22 |
1.73 |
2.34 |
营业额增长(%) |
-17.8 |
-20.55 |
10.35 |
-7.99 |
6.31 |
-4.56 |
23.31 |
15.88 |
14.38 |
2.31 |
0.0 |
119.4 |
59.13 |
6.56 |
2.3 |
20.38 |
股东应占溢利增长(%) |
6.34 |
41.3 |
2.28 |
-19.44 |
-13.94 |
23.87 |
12.79 |
23.16 |
42.89 |
-40.88 |
0.0 |
|
251.2 |
-21.72 |
-2.69 |
-0.19 |
核数师意见 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|